Article info
Epidemiology
Original research
Cost-effectiveness of two screening strategies for Chlamydia trachomatis and Neisseria gonorrhoeae as part of the PrEP programme in the Netherlands: a modelling study
- Correspondence to Dr Elske Hoornenborg, Department of Infectious Diseases, Public Health Service of Amsterdam, 1018 WT Amsterdam, Netherlands; ehoornenborg{at}ggd.amsterdam.nl
Citation
Cost-effectiveness of two screening strategies for Chlamydia trachomatis and Neisseria gonorrhoeae as part of the PrEP programme in the Netherlands: a modelling study
Publication history
- Received August 11, 2020
- Revised November 27, 2020
- Accepted December 6, 2020
- First published January 11, 2021.
Online issue publication
January 07, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.